Moreover, the role, if any, of visfatin in NAFLD development and the mechanisms involved have been rarely studied; we evaluated the effects of visfatin on hepatic insulin resistance and inflammation using HepG2 cells. The gene discussed is NAMPT; the disease is metabolic dysfunction-associated steatotic liver disease.